- Home
- PCRX vs MNTK Comparison
PCRX vs MNTK Comparison
Compare PCRX & MNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- MNTK
- Stock Information
- Founded
- PCRX 2006
- MNTK 1980
- Country
- PCRX United States
- MNTK United States
- Employees
- PCRX N/A
- MNTK N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- MNTK Natural Gas Distribution
- Sector
- PCRX Health Care
- MNTK Utilities
- Exchange
- PCRX Nasdaq
- MNTK Nasdaq
- Market Cap
- PCRX 604.7M
- MNTK 622.2M
- IPO Year
- PCRX 2011
- MNTK 2021
- Fundamental
- Price
- PCRX $24.52
- MNTK $4.51
- Analyst Decision
- PCRX Buy
- MNTK Hold
- Analyst Count
- PCRX 10
- MNTK 2
- Target Price
- PCRX $27.60
- MNTK $6.00
- AVG Volume (30 Days)
- PCRX 687.3K
- MNTK 164.7K
- Earning Date
- PCRX 02-27-2025
- MNTK 03-13-2025
- Dividend Yield
- PCRX N/A
- MNTK N/A
- EPS Growth
- PCRX N/A
- MNTK 42.11
- EPS
- PCRX N/A
- MNTK 0.16
- Revenue
- PCRX $694,957,000.00
- MNTK $194,849,000.00
- Revenue This Year
- PCRX $4.83
- MNTK $21.28
- Revenue Next Year
- PCRX $2.16
- MNTK $31.59
- P/E Ratio
- PCRX N/A
- MNTK $28.44
- Revenue Growth
- PCRX 4.40
- MNTK 9.63
- 52 Week Low
- PCRX $11.16
- MNTK $3.38
- 52 Week High
- PCRX $34.01
- MNTK $7.75
- Technical
- Relative Strength Index (RSI)
- PCRX 76.79
- MNTK 56.40
- Support Level
- PCRX $18.18
- MNTK $4.18
- Resistance Level
- PCRX $22.36
- MNTK $4.24
- Average True Range (ATR)
- PCRX 1.28
- MNTK 0.25
- MACD
- PCRX 0.39
- MNTK 0.04
- Stochastic Oscillator
- PCRX 89.19
- MNTK 60.00
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About MNTK Montauk Renewables Inc.
Montauk Renewables Inc is a United States-based renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments: Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.